Frequently Asked Questions: Incontinence
1. Why is incontinence sometimes a side effect of surgery (whether robotic or open procedure) for prostate cancer?
A: Surgical dissection is performed in close proximity to the urethral sphincter muscle. This muscle is used for urinary control and can sometimes be damaged with surgery. Increased visualization and improved techniques with robotic surgery significantly decreases the risk of incontinence. Learn More>> Robotic surgery for prostate cancer.
2. Why is incontinence sometimes a side effect of radiation therapy for prostate cancer?
A: Radiation and X-Rays can sometimes damage the urethral sphincter or affect bladder function, causing the bladder to contract abnormally, resulting in urinary leakage. Learn More>> Radiation therapy options for prostate cancer.
3. Is there anything I can do for post-treatment incontinence?
A: Perform Kegel exercises, avoid too much physical activity too early after surgery and do not allow too much time to pass between voids, in other words urinate every 2-3 hrs. Learn More>> WebMD article (March 20, 2009): Kegel Exercises: Treating Male Urinary Incontinence.
4. Is there anything I can do before treatment to help prevent incontinence?
A: Physical therapy for urinary incontinence has been shown to be beneficial and decrease rates of post-treatment urinary incontinence.
5. What is the proper procedure for performing Kegel exercises?
A: Bear down as if you are trying to interrupt the flow of your urinary stream. Perform this at least 5-10 times in a row, 2-3 times per day. Learn More>> WebMD article (March 20, 2009): Kegel Exercises: Treating Male Urinary Incontinence.
We encourage you to contact our Patient Navigator at (678) 843-5665 or renee.sevy@emoryhealthcare.org with any questions you have regarding incontinence after treatment for prostate cancer.
Information on this page is provided collaboratively by the team at the Prostate Cancer Center at Saint Joseph's and has been medically reviewed by Rajesh G. Laungani, MD, 2010. The PCC follows American Urological Association and National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for the treatment of prostate cancer.
Last Updated: October 14, 2010 (RSH)

